$50.27
0.8%
Price vs. AI Score (Last 150 days)
Data gathered: December 7
Data gathered: December 7
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 1,250 0% |
|
| Sentiment | 85 -4.5% |
|
| Webpage traffic | 1,185,000 -6.5% |
|
| Employee Rating | 76 -1.3% |
|
| Google Adspend | $408 5.2% |
|
| Google Trends | -100% |
|
| Linkedin Employees | 36,274 N/A |
|
| Lobbying Cost | $727,000 0% |
|
| Patents | 1,042 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 3,444 1.2% |
|
| Facebook followers | 132,983 0% |
|
| Stocktwits Mentions | 22 22.2% |
|
| Stocktwits Subscribers | 18,102 0% |
|
| Twitter Followers | 156,791 0% |
|
| Youtube Subscribers | 3,280 0% |
|
| Instagram Followers | 19,371 0.1% |
|
| News Mentions | 2 -50% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 62 0% |
|
In the news
Bristol Myers : 5% dividend increaseDecember 6 - Finnhub |
|
 |
Bristol Myers Squibb Announces Dividend IncreaseDecember 6 - Yahoo |
 |
Best Penny Stocks To Buy? 4 To Watch With Big News This WeekDecember 6 - PennyStocks |
Bristol Myers Squibb Raises Dividend 5.3%, to 60 CentsDecember 6 - Finnhub |
|
 |
Hedge Funds are Betting on These 14 Sliding StocksDecember 6 - Yahoo |
Gene Therapy Market projected to reach USD 38.33 Billion by 2030, growing at a CAGR of 22.2% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent studyDecember 6 - GlobeNewswire |
|
About Bristol-Myers Squibb
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
| Price | $50.27 |
| Target Price | Sign up |
| Market Cap | $101B |
| Dividend Yield | 0.0454 |
| Industry | Drug Manufacturers |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$155.65 0.6% | 47 |
 |
Eli Lilly and CompanyLLY |
$588.23 0.6% | 66 |
 |
PfizerPFE |
$28.69 0.3% | 51 |
 |
AstrazenecaAZN |
$63.54 0.3% | 64 |
 |
AbbVieABBV |
$147.97 0.7% | 52 |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 11B | 6.93B | 4.03B | 1.93B | 4.71B |
| Q2 '23 | 11.2B | 7.22B | 4.01B | 2.07B | 4.44B |
| Q1 '23 | 11.3B | 6.8B | 4.54B | 2.26B | 5.35B |
| Q4 '22 | 11.4B | 7.41B | 4B | 2.02B | 4.45B |
| Q3 '22 | 11.2B | 6.97B | 4.25B | 1.61B | 5.01B |
Insider Transactions
| BOERNER CHRISTOPHER S. filed to buy 79,384 shares at $48.9. November 30 '23 |
| Samuels Theodore R. II filed to buy 35,500 shares at $49.8. November 21 '23 |
| Powell Ann filed to sell 27,868 shares at $61.3. August 28 '23 |
| Plenge Robert M filed to sell 6,584 shares at $61.1. August 7 '23 |
| VESSEY RUPERT filed to sell 47,751 shares at $67.1. May 4 '23 |
Read more about Bristol-Myers Squibb and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, lobbying cost, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, business outlook.